(Q73048666)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9024731%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

N-acetylcysteine attenuates nitroglycerin tolerance in patients with angina pectoris and normal left ventricular function (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9024731%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

L Pizzulli

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9024731%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

A Hagendorff

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9024731%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

M Zirbes

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9024731%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

W Jung

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9024731%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

B Lüderitz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9024731%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

language of work or name

English

0 references

publication date

1 January 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9024731%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Cardiology

31 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9024731%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9024731%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9024731%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

28-33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9024731%20AND%20SRC:MED&resulttype=core&format=json

Tolerance to organic nitrates

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900671-6

Tolerance to isosorbide dinitrate: rate of development and reversal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900671-6

Incidence of early tolerance to hemodynamic effects of continuous infusion of nitroglycerin in patients with coronary artery disease and heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900671-6

Prevention and reversal of tolerance to nitroglycerine with N-acetylcysteine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900671-6

In vivo induction and reversal of nitroglycerin tolerance in human coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900671-6

Prevention and reversal of nitrate tolerance in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900671-6

Preventive administration of intravenous N-acetylcysteine and development of tolerance to isosorbide dinitrate in patients with angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900671-6

Altered peripheral vesodilator profile of nitroglycerin during long-term infusion of N-acetylcysteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900671-6

Tolerance to intravenous nitroglycerin in patients with congestive heart failure: role of increased intravascular volume, neurohumoral activation and lack of prevention with N-acetylcysteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900671-6

Different susceptibility to the development of nitroglycerin tolerance in the arterial and venous circulation in humans. Effects of N-acetylcysteine administration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900671-6

Altered spectrum of nitroglycerin action in long-term treatment: nitroglycerin-specific venous tolerance with maintenance of arterial vasodepressor potency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900671-6

Counter-regulatory responses to continuous and intermittent therapy with nitroglycerin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900671-6

Hemodynamic and hormonal response to transdermal nitroglycerin in normal subjects and in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900671-6

Prevention of nitrate tolerance with angiotension converting enzyme inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900671-6

Influence of captopril on nitroglycerin-mediated vasodilation and development of nitrate tolerance in arterial and venous circulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900671-6

Failure of captopril to prevent nitrate tolerance in congestive heart failure secondary to coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900671-6

Nitrate tolerance: the lack of effect of N-acetylcysteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900671-6

Determinants of in vitro nitroglycerin tolerance induction and reversal: influence of dose regimen, nitrate-free period, and sulfhydryl supplementation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900671-6

Potentiation of isosorbide dinitrate-induced coronary dilatation by captopril

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900671-6

Potentiation of the cardiovascular effects of nitroglycerin by N-acetylcysteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900671-6

Methionine restores the venodilative response to nitroglycerin after the development of tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900671-6

Potentiation of nitroglycerin-induced coronary dilatation by N-acetylcysteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900671-6

Nitrate tolerance in epicardial arteries or in the venous system is not reversed by N-acetylcysteine in vivo, but tolerance-independent interactions exist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900671-6

Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900671-6

Nitrate tolerance in vivo is not associated with depletion of arterial or venous thiol levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900671-6

10.1016/S0002-9149(96)00671-6

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9024731%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference